Macrophage inflammatory protein-1α: A salivary biomarker of bone loss in a longitudinal cohort study of children at risk for aggressive periodontal disease?

Journal of Periodontology

Volumn 80, Issue 1, 2009, Pages 106-113

  Fine, Daniel H ^a   Markowitz, Kenneth ^a   Furgang, David ^a   Fairlie, Karen ^a   Ferrandiz, Javier ^a   Nasri, Cebile ^a   McKiernan, Marie ^a   Donnelly, Robert ^b   Gunsolley, John ^c  

^a RUTGERS SCHOOL OF DENTAL MEDICINE   (United States)

^b RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^c VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

Aggregatibacter actinomycetemcomitans; Bone loss; Interleukin 1 beta; Macrophage inflammatory protein 1 alpha

Indexed keywords

BIOLOGICAL MARKER; INTERLEUKIN 1BETA; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; SALIVA PROTEIN;

ACTINOBACILLUS ACTINOMYCETEMCOMITANS; ADOLESCENT; ARTICLE; CASE CONTROL STUDY; CHILD; COHORT ANALYSIS; COMPARATIVE STUDY; DISEASE PREDISPOSITION; FEMALE; HUMAN; IMMUNOLOGY; ISOLATION AND PURIFICATION; LONGITUDINAL STUDY; MALE; MICROBIOLOGY; OSTEOLYSIS; PERIODONTAL DISEASE; PERIODONTITIS; PERIODONTIUM; RISK FACTOR; SALIVA; SENSITIVITY AND SPECIFICITY;

ACTINOBACILLUS ACTINOMYCETEMCOMITANS; ADOLESCENT; AGGRESSIVE PERIODONTITIS; ALVEOLAR BONE LOSS; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHEMOKINE CCL3; CHILD; COHORT STUDIES; DISEASE SUSCEPTIBILITY; FEMALE; HUMANS; INTERLEUKIN-1BETA; LONGITUDINAL STUDIES; MALE; PERIODONTAL ATTACHMENT LOSS; PERIODONTAL POCKET; PERIODONTIUM; RISK FACTORS; SALIVA; SALIVARY PROTEINS AND PEPTIDES; SENSITIVITY AND SPECIFICITY;

EID: 58349114478     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2009.080296     Document Type: Article

References (40)

1. Löe H, Theilade E, Jensen SB. Experimental gingivitis in man. J Periodontol 1965;36:177-187.
2. Listgarten MA. The role of dental plaque in gingivitis and periodontitis. J Clin Periodontol 1988;15:485-487.
3. Socransky SS, Haffajee AD. The bacterial etiology of destructive periodontal disease: A historical perspective. J Periodontol 1992;63:322-331.
4. Albandar JM. Global risk factors and risk indicators for periodontal diseases. Periodontol 2000 2002;29:177-206.
5. Offenbacher S, Barros SP, Singer RE, Moss K, Williams RC, Beck JD. Periodontal disease at the biofilm-gingival interface. J Periodontol 2007;78:1911-1925.
6. Agace WW, Hedges SR, Ceska M, Svanborg C. Interleukin-8 and the neutrophil response to mucosal gram-negative infection. J Clin Invest 1993;92:780-785.
7. Graves DT, Fine D, Teng Y-T, Van Dyke TE, Hajishengallis G. The use of rodent models to investigate host-bacteria interactions related to periodontal diseases. J Clin Periodontol 2008;35:89-105.
8. Fine DH, Markowitz K, Furgang D, et al. Aggregatibacter actinomycetemcomitans and its relationship to initiation of localized aggressive periodontitis: Longitudinal cohort study of initially healthy adolescents. J Clin Microbiol 2007;45:3859-3869.
9. Bueno LC, Mayer MP, DiRienzo JM. Relationship between conversion of localized juvenile periodontitis-susceptible children from health to disease and Actinobacillus actinomycetemcomitans leukotoxin promoter structure. J Periodontol 1998;69:998-1007.
10. Haubek D, Ennibi O-K, Poulsen K, Vaeth M, Poulsen S, Kilian M. Risk of aggressive periodontitis in adolescent carriers of the JP2 clone of Aggregatibacter (Actinobacillus) actinomycetemcomitans in Morocco: A prospective longitudinal cohort study. Lancet 2008;371:237-242.
11. Zambon JJ. Actinobacillus actinomycetemcomitans in human periodontal disease. J Clin Periodontol 1985;12:1-20.
12. Fives-Taylor PM, Meyer DH, Mintz KP, Brissette C. Virulence factors of Actinobacillus actinomycetemcomitans. Periodontol 2000 1999;20:136-167.
13. Pihlstrom BL, Michalowicz BS, Johnson NW. Periodontal diseases. Lancet 2005;366:1809-1820.
14. Hu S, Loo JA, Wong DA. Human saliva proteome analysis. Ann N Y Acad Sci 2007;1098:323-329.
15. Listgarten MA. Periodontal probing: What does it mean? J Clin Periodontol 1980;7:165-176.
16. Rams TE, Listgarten MA, Slots J. Utility of radiographic crestal alveolar lamina dura for predicting periodontitis disease-activity. J Clin Periodontol 1994;21:571-576.
17. Goodson JM, Haffajee AD, Socransky SS. The relationship between attachment level loss and alveolar bone loss. J Clin Periodontol 1984;11:348-359.
18. Lamster IB, Oshrain RL, Harper DS, Celenti RS, Hovliaras CA, Gordon JM. Enzyme activity in crevicular fluid for detection and prediction of clinical attachment loss in patients with chronic adult periodontitis. Six month results. J Periodontol 1988;59:516-523.
19. Albandar JM. Prevalence of incipient radiographic periodontal lesions in relation to ethnic background and dental care provisions in young adults. J Clin Periodontol 1989;16:625-629.
20. Lopez NJ, Rios V, Pareja MA, Fernandez O. Prevalence of juvenile periodontitis in Chile. J Clin Periodontol 1991;18:529-533.
21. Listgarten MA. A perspective on periodontal diagnosis. J Clin Periodontol 1986;13:175-181.
22. Armitage GC. Periodontal diagnoses and classification of periodontal diseases. Periodontol 2000 2004;34:9-21.
23. Eickholz P, Hausmann E. Accuracy of radiographic assessment of interproximal bone loss in intrabony defects using linear measurements. Eur J Oral Sci 2000;108:70-73.
24. Bragger U, Pasquali L, Rylander H, Carnes D, Kornman KS. Computer-assisted densitometric image analysis in periodontal radiography. J Clin Periodontol 1988;15:27-37.
25. Loftin R, Webber R, Horton R, Tyndall D, Moriarty J. Effect of projective aspect variations on estimates of changes in bone mass using digital subtraction radiography. J Periodontal Res 1998;33:352-358.
26. Hausmann E, Allen K, Loza J, Buchanan W, Cavanaugh PF. Validation of quantitative digital subtraction radiography using the electronically guided alignment device/impression technique. J Periodontol 1996;67:895-899.
27. Löe H, Brown LJ. Early onset periodontitis in the United States of America. J Periodontol 1991;62:608-616.
28. Engebretson SP, Grbic JT, Singer R, Lamster IB. GCF IL-1beta profiles in periodontal disease. J Clin Periodontol 2002;29:48-53.
29. Aggarwal R, Ghobrial IM, Roodman GD. Chemokines inmultiplemyeloma. Exp Hematol 2006;34:1289-1295.
30. Luster AD. Chemokines-chemotactic cytokines that mediate inflammation. N Engl J Med 1998;338:436-445.
31. Roodman GD. Regulation of osteoclast differentiation. Ann N Y Acad Sci 2006;1068:100-109.
32. Choi SJ, Cruz JC, Craig F, et al. Macrophage inflammatory protein-1-alpha is a potential osteoclast stimulatory factor in multiple myeloma. Blood 2000;96:671-675.
33. Silva TA, Garlet GP, Lara VS, Martins W, Silva JS, Cunha FQ. Differential expression of chemokines and chemokine receptors in inflammatory periapical diseases. Oral Microbiol Immunol 2005;20:310-316.
34. Garlet GP, Martins W Jr., Ferreira BR, Milanezi CM, Silva JS. Patterns of chemokines and chemokine receptors expression in different forms of human periodontal disease. J Periodontal Res 2003;38:210-217.
35. Emingil G, Atilla G, Baskesen A, Berdeli A. Gingival crevicular fluid EMAP-II, MIP-1alpha and MIP-1beta levels of patients with periodontal disease. J Clin Periodontol 2005;32:880-885.
36. Lee H-J, Kang I-K, Chang C-P, Choi S-M. The subgingival microflora and gingival crevicular fluid cytokines in refractory periodontitis. J Clin Periodontol 1995;22:885-890.
37. Hou LT, Liu C-M, Rossomando EF. Crevicular interleukin-1 beta in moderate and severe periodontitis patients and the effects of phase 1 periodontal therapy. J Clin Periodontol 1995;22:162-167.
38. Rogers MA, Figliomeni L, Baluchova K, et al. Do interleukin-1 polymorphisms predict the development of periodontitis or the success of dental implants? J Periodontal Res 2002;37:37-41.
39. Ryu OH, Choi SJ, Linares AMG, et al. Gingival epithelial cell expression of macrophage inflammatory protein-1-alpha induced by interleukin-1-beta and lipopolysaccharide. J Periodontol 2007;78:1627-1634.
40. Greenstein G. Contemporary interpretation of probing depth assessments: Diagnostic and therapeutic implications. A literature review. J Periodontol 1997;68:1194-1203.